IDENTIFICATION OF AN ENDOGENOUS 2-MONOGLYCERIDE, PRESENT IN CANINE GUT, THAT BINDS TO CANNABINOID RECEPTORS

被引:2186
作者
MECHOULAM, R
BENSHABAT, S
HANUS, L
LIGUMSKY, M
KAMINSKI, NE
SCHATZ, AR
GOPHER, A
ALMOG, S
MARTIN, BR
COMPTON, DR
PERTWEE, RG
GRIFFIN, G
BAYEWITCH, M
BARG, J
VOGEL, Z
机构
[1] MICHIGAN STATE UNIV,DEPT PHARMACOL & TOXICOL,E LANSING,MI 48824
[2] CHAIM SHEBA MED CTR,INST CLIN PHARMACOL & TOXICOL,IL-52621 TEL HASHOMER,ISRAEL
[3] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298
[4] UNIV ABERDEEN,MARISCHAL COLL,DEPT BIOMED SCI,ABERDEEN AB9 1AS,SCOTLAND
[5] WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL
基金
英国惠康基金;
关键词
2-ARACHIDONYL GLYCEROL; ANAND AMIDE; TETRAHYDROCANNABINOL; ARACHIDONYLETHANOLAMIDE; IMMUNE SYSTEM; TRANSFECTION; MOUSE BEHAVIOR; ADENYLATE CYCLASE INHIBITION;
D O I
10.1016/0006-2952(95)00109-D
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we report the isolation from canine intestines of 2-arachidonyl glycerol (2-Ara-Gl). Its structure was determined by mass spectrometry and by direct comparison with a synthetic sample. 2-Ara-Gl bound to membranes from cells transiently transfected with expression plasmids carrying DNA of either CB1 or CB2-the two cannabinoid receptors identified thus far-with K-i values of 472 +/- 55 and 1400 +/- 172 nM, respectively. In the presence of forskolin, 2-Ara-Gl inhibited adenylate cyclase in isolated mouse spleen cells, at the potency level of Delta(9)-tetrahydrocannabinol (Delta(9)-THC). Upon intravenous administration to mice, 2-Ara-Gl caused the typical tetrad of effects produced by THC: antinociception, immobility, reduction of spontaneous activity, and lowering of the rectal temperature. 2-Ara-Gl also shares the ability of Delta(9)-THC to inhibit electrically evoked contractions of mouse isolated vasa deferentia; however, it was less potent than Delta(9)-THC.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 37 条
  • [11] PHARMACOLOGICAL ACTIVITY OF THE CANNABINOID RECEPTOR AGONIST, ANANDAMIDE, A BRAIN CONSTITUENT
    FRIDE, E
    MECHOULAM, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (02) : 313 - 314
  • [12] GAONI Y, 1991, J AM CHEM SOC, V93, P217
  • [13] MOLECULAR-CLONING OF A HUMAN CANNABINOID RECEPTOR WHICH IS ALSO EXPRESSED IN TESTIS
    GERARD, CM
    MOLLEREAU, C
    VASSART, G
    PARMENTIER, M
    [J]. BIOCHEMICAL JOURNAL, 1991, 279 : 129 - 134
  • [14] GUNSTONE FD, 1979, COMPREHENSIVE ORGANI, V5, P633
  • [15] 2 NEW UNSATURATED FATTY-ACID ETHANOLAMIDES IN BRAIN THAT BIND TO THE CANNABINOID RECEPTOR
    HANUS, L
    GOPHER, A
    ALMOG, S
    MECHOULAM, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (20) : 3032 - 3034
  • [16] JARBE TUC, 1993, J PHARMACOL EXP THER, V264, P561
  • [17] KAMINSKI NE, 1992, MOL PHARMACOL, V42, P736
  • [18] SUPPRESSION OF THE HUMORAL IMMUNE-RESPONSE BY CANNABINOIDS IS PARTIALLY MEDIATED THROUGH INHIBITION OF ADENYLATE-CYCLASE BY A PERTUSSIS-TOXIN-SENSITIVE G-PROTEIN COUPLED MECHANISM
    KAMINSKI, NE
    KOH, WS
    YANG, KH
    LEE, M
    KESSLER, FK
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) : 1899 - 1908
  • [19] CANNABINOIDS - STRUCTURE-ACTIVITY STUDIES RELATED TO 1,2-DIMETHYLHEPTYL DERIVATIVES
    LOEV, B
    BENDER, PE
    DOWALO, F
    MACKO, E
    FOWLER, PJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (11) : 1200 - 1206
  • [20] LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612